nilutamide has been researched along with Breast Neoplasms in 5 studies
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medroxyprogesterone acetate (MPA), which is frequently used as second line hormonal therapy for the treatment of metastatic breast cancer, binds with high affinity to the progesterone receptor (PR)." | 7.70 | Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. ( Bentel, JM; Birrell, SN; Holds, DJ; Horsfall, DJ; Pickering, MA; Tilley, WD, 1999) |
| "Medroxyprogesterone acetate (MPA), which is frequently used as second line hormonal therapy for the treatment of metastatic breast cancer, binds with high affinity to the progesterone receptor (PR)." | 3.70 | Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. ( Bentel, JM; Birrell, SN; Holds, DJ; Horsfall, DJ; Pickering, MA; Tilley, WD, 1999) |
| "Although the majority of primary human breast cancers express the androgen receptor (AR), the role of androgens in breast cancer growth and progression is poorly understood." | 1.29 | Androgens induce divergent proliferative responses in human breast cancer cell lines. ( Bentel, JM; Birrell, SN; Hickey, TE; Horsfall, DJ; Ricciardelli, C; Tilley, WD; Weger, MA, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simard, J | 1 |
| Singh, SM | 1 |
| Labrie, F | 1 |
| Birrell, SN | 2 |
| Bentel, JM | 2 |
| Hickey, TE | 1 |
| Ricciardelli, C | 1 |
| Weger, MA | 1 |
| Horsfall, DJ | 2 |
| Tilley, WD | 2 |
| Pickering, MA | 1 |
| Holds, DJ | 1 |
| Millward, MJ | 1 |
| Cantwell, BM | 1 |
| Dowsett, M | 1 |
| Carmichael, J | 1 |
| Harris, AL | 1 |
| Namer, M | 1 |
1 review available for nilutamide and Breast Neoplasms
| Article | Year |
|---|---|
Clinical applications of antiandrogens.
Topics: Androgen Antagonists; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Female; Flutamide; Humans; | 1988 |
1 trial available for nilutamide and Breast Neoplasms
| Article | Year |
|---|---|
Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Estradiol; Female | 1991 |
3 other studies available for nilutamide and Breast Neoplasms
| Article | Year |
|---|---|
Comparison of in vitro effects of the pure antiandrogens OH-flutamide, Casodex, and nilutamide on androgen-sensitive parameters.
Topics: Androgen Antagonists; Anilides; Animals; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carri | 1997 |
Androgens induce divergent proliferative responses in human breast cancer cell lines.
Topics: Androgen Receptor Antagonists; Androgens; Breast Neoplasms; Cell Division; Dihydrotestosterone; Flut | 1995 |
Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Topics: Androgen Antagonists; Androgens; Antineoplastic Agents; Binding, Competitive; Breast Neoplasms; Cell | 1999 |